Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity

被引：0

作者：

Linong Ji

Jie Liu

Zhi Jin Xu

Zhiqi Wei

Ruya Zhang

Seema Malkani

Nilo B. Cater

Robert Frederich

机构：

[1] Peking University People’s Hospital,Endocrinology and Metabolism

[2] Global Clinical Development,Biostatistics

[3] MRL,Global Medical Affairs

[4] Merck & Co.,Global Medical and Scientific Affairs

[5] Inc.,Global Medical Affairs

[6] Merck & Co.,Clinical Development and Operations

[7] Inc.,undefined

[8] MRL,undefined

[9] MSD China,undefined

[10] MRL,undefined

[11] Merck & Co.,undefined

[12] Inc.,undefined

[13] Pfizer Inc.,undefined

[14] Pfizer Inc.,undefined

来源：

Diabetes Therapy | 2023年 / 14卷

关键词：

Asia; Ertugliflozin; Obese; Overweight; Type 2 diabetes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：319 / 334

页数：15

共 50 条

[1] Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity
Ji, Linong
Liu, Jie
Xu, Zhi Jin
Wei, Zhiqi
Zhang, Ruya
Malkani, Seema
Cater, Nilo B.
Frederich, Robert
[J]. DIABETES THERAPY, 2023, 14 (2) : 319 - 334
[2] Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus
Heymsfield, Steven B.
Raji, Annaswamy
Gallo, Silvina
Liu, Jie
Pong, Annpey
Hannachi, Hakima
Terra, Steven G.
[J]. OBESITY, 2020, 28 (04) : 724 - 732
[3] Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phaseIIIstudies
Pratley, Richard
Charbonnel, Bernard
Patel, Shrita
Hickman, Anne
Liu, Jie
Tarasenko, Lisa
Pong, Annpey
Ellison, Misoo C.
Huyck, Susan
Gantz, Ira
Terra, Steven G.
[J]. DIABETES OBESITY & METABOLISM, 2020, 22 (12): : 2276 - 2286
[4] Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia
Ji, Linong
Liu, Yanmei
Miao, Heng
Xie, Yongli
Yang, Ming
Wang, Wei
Mu, Yuting
Yan, Ping
Pan, Sharon
Lauring, Brett
Liu, Shu
Huyck, Susan
Qiu, Yanping
Terra, Steven G.
[J]. DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1474 - 1482
[5] Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS-Asia
Yang, M.
Ji, L.
Liu, Y.
Miao, H.
Xie, Y.
Wang, W.
Mu, Y.
Yan, P.
Pan, S.
Lauring, B.
Liu, S.
Huyck, S.
Wang, D.
Terra, S. G.
[J]. DIABETOLOGIA, 2018, 61 : S307 - S308
[6] A Pooled Analysis of the Efficacy and Safety of Ertugliflozin as Add-On Therapy to Metformin
Calle, Roberto A.
Liu, Jie
Huyck, Susan
Wu, Larry
Pong, Annpey
Mancuso, James P.
Terra, Steven
Lauring, Brett
[J]. DIABETES, 2018, 67
[7] A pooled analysis of the efficacy and safety of ertugliflozin as add-on therapy to metformin
Calle, R. A.
Liu, J.
Huyck, S.
Wu, L.
Pong, A.
Mancuso, J. P.
Terra, S. G.
Lauring, B.
[J]. DIABETOLOGIA, 2018, 61 : S303 - S303
[8] Safety and efficacy of Ertugliflozin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy in the VERTIS-Asia study
Yang, Ming
Ji, Linong
Liu, Yanmei
Miao, Heng
Xie, Yongli
Wang, Wei
Mu, Yuting
Yan, Ping
Pan, Sharon
Lauring, Brett
Liu, Shu
Huyck, Susan
Wang, Yinna
Terra, Steven G.
[J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
[9] Efficacy and safety of alogliptin added to metformin therapy in patients with type 2 diabetes
Nauck, Michael
Ellis, Graham
Fleck, Penny
Wilson, Craig
Mekki, Qais
[J]. DIABETES, 2008, 57 : A142 - A143
[10] Efficacy and safety of ertugliflozin in patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS MET trial
Charbonnel, B.
Pascu, R.
Frias, J.
Pall, D.
Saur, D.
Darekar, A.
Huyck, S.
Shi, H.
Lauring, B.
Terra, S.
Rosenstock, J.
[J]. DIABETOLOGIA, 2017, 60 : S406 - S407

← 1 2 3 4 5 →